Research location
Flushing
New York, United States
Advertisement
Research activity in Flushing
New York, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 98 trials and 100 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Flushing
98 linked trials · page 1 of 2Decision Support Tool for Patients With Advanced Breast CancerNCT07635147 · 2026-06-17 · 1 site observation
RECRUITING
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary DiseaseNCT07363694 · 2026-02-11 · 1 site observation
RECRUITING
CHIME: Comparing Health Interventions for Maternal EquityNCT06724172 · 2026-01-22 · 1 site observation
RECRUITING
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart FailureNCT07069738 · 2025-10-22 · 1 site observation
RECRUITING
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus TrastuzumabNCT06876714 · 2025-09-17 · 1 site observation
RECRUITING
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic PhenotypeNCT07190209 · 2025-09-16 · 1 site observation
RECRUITING
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate CancerNCT05946213 · 2023-12-14 · 1 site observation
RECRUITING
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25NCT05879926 · 2023-10-18 · 1 site observation
RECRUITING
Clinical Trial of Approaches to Prostate Cancer SurgeryNCT05155501 · 2023-05-15 · 1 site observation
RECRUITING
Comparison of the Body Roundness Index and A Body Shape Index With Body Fat and Visceral Fat in People Living With HIV.NCT07203261 · 2025-09-25 · 1 site observation
NOT_YET_RECRUITING
Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam TrialNCT06671912 · 2025-02-19 · 1 site observation
SUSPENDED
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the BrainNCT06500455 · 2024-12-12 · 1 site observation
ACTIVE_NOT_RECRUITING
Combination Immunotherapy in Colorectal CancerNCT05571293 · 2023-03-17 · 1 site observation
ACTIVE_NOT_RECRUITING
Diabetes Care for Breast Cancer PatientsNCT05565534 · 2023-02-28 · 1 site observation
COMPLETED
A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPDNCT04320342 · 2022-04-27 · 1 site observation
COMPLETED
A Global Study to Assess the Effects of Osimertinib in Participants With EGFRm Stage IA2-IA3 NSCLC Following Complete Tumour ResectionNCT05120349 · 2022-02-21 · 1 site observation
ACTIVE_NOT_RECRUITING
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance TrialNCT05050084 · 2021-12-06 · 1 site observation
ACTIVE_NOT_RECRUITING
A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation TherapyNCT04455750 · 2021-10-14 · 1 site observation
ACTIVE_NOT_RECRUITING
Study Evaluating the Safety and Efficacy of Islatravir in Combination With Lenacapavir in Virologically Suppressed People With HIVNCT05052996 · 2021-10-05 · 1 site observation
ACTIVE_NOT_RECRUITING
A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung CancerNCT04951115 · 2021-07-12 · 1 site observation
TERMINATED
PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy 2NCT04815876 · 2021-06-24 · 1 site observation
COMPLETED
PReclude Infection EVEnts With No Prophylaxis Transperineal BiopsyNCT04843566 · 2021-03-22 · 1 site observation
COMPLETED
Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)NCT04751487 · 2021-02-12 · 1 site observation
COMPLETED
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT TrialNCT04513717 · 2021-01-21 · 1 site observation
ACTIVE_NOT_RECRUITING
An Observational Study of Beta-Blocker Use in Patients With COPD and Acute MINCT04717492 · 2020-06-28 · 1 site observation
COMPLETED
CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted TherapyNCT04266249 · 2020-03-13 · 1 site observation
ACTIVE_NOT_RECRUITING
Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of RecurringNCT04037254 · 2019-10-08 · 1 site observation
COMPLETED
Physical Activity and People Living With HIV in New York CityNCT07091253 · 2019-08-05 · 1 site observation
TERMINATED
Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF)NCT03988634 · 2019-06-29 · 1 site observation
COMPLETED
QP ExCELs: MultiPole Pacing (MPP) Sub-StudyNCT03155724 · 2017-05-19 · 1 site observation
COMPLETED
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation TherapyNCT02927249 · 2017-01-06 · 1 site observation
TERMINATED
Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MINCT02924727 · 2016-12-09 · 1 site observation
COMPLETED
Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)NCT02973789 · 2016-12-01 · 1 site observation
COMPLETED
INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart FailureNCT02787044 · 2016-08-01 · 3 site observations
COMPLETED
Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseNCT02587351 · 2016-05-01 · 1 site observation
TERMINATED
Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular MarkersNCT02808494 · 2016-03-01 · 1 site observation
COMPLETED
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney DiseaseNCT02540993 · 2015-09-17 · 1 site observation
COMPLETED
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 DiabetesNCT02460978 · 2015-07-08 · 1 site observation
COMPLETED
Chronic Hypertension and Pregnancy (CHAP) ProjectNCT02299414 · 2015-06-01 · 1 site observation
COMPLETED
Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular LeadsNCT02290028 · 2014-12-16 · 1 site observation
TERMINATED
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection FractionNCT01920711 · 2014-07-18 · 1 site observation
COMPLETED
Efficacy, Safety, and Tolerability of Selonsertib (GS-4997) in Participants With Diabetic Kidney DiseaseNCT02177786 · 2014-06-01 · 1 site observation
COMPLETED
Switch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDFNCT02121795 · 2014-05-06 · 1 site observation
COMPLETED
Same Day Discharge (SDD) After Implantable Cardioverter Defibrillator (ICD) ImplantNCT01993862 · 2014-03-17 · 1 site observation
COMPLETED
Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With ChemotherapyNCT01901094 · 2014-02-24 · 1 site observation
ACTIVE_NOT_RECRUITING
Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive AdultsNCT01968551 · 2013-09-03 · 1 site observation
COMPLETED
Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic NephropathyNCT01874431 · 2013-06-12 · 1 site observation
COMPLETED
Cardiovascular Inflammation Reduction TrialNCT01594333 · 2013-04-01 · 1 site observation
COMPLETED
Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive ParticipantsNCT01815736 · 2013-03-27 · 1 site observation
COMPLETED
Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney DiseaseNCT01752985 · 2013-03-18 · 1 site observation
TERMINATED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.